Home
|
About IAC
|
Contact
|
A-Z Index
|
Donate
|
Shop
|
SUBSCRIBE
Immunization Action Coalition
IAC Express 2009
Issue number 807: June 22, 2009
Please click here to subscribe to IAC Express as well as other FREE IAC periodicals.
Contents of this Issue
Select a title to jump to the article.
  1. Reminder: Please take IAC's survey about immunization education materials
  2. MMWR article reports on healthcare personnel who may have acquired novel H1N1 influenza infection from ill patients
  3. CDC's novel H1N1 influenza web section is updated with guidance for day/residential camps, PSAs on travel and leaving home when sick, and more
  4. WHO reports that sanofi pasteur will donate 100 million doses of pandemic H1N1 influenza vaccine
  5. IAC updates its website with redesigned hepatitis B and HPV web sections; links to package inserts and a sortable language-locator table are also available
  6. IAC adds new Q&As to 14 of its "Ask the Experts" web sections
  7. IAC's Video of the Week features a polio survivor's story about her 60 years in an iron lung
  8. FDA enforces laws to protect consumers from Internet marketing of illegal products related to novel H1N1 influenza
  9. Order laminated U.S. immunization schedules today!
  10. CDC updates its online VIS fact sheet with information about new options for distributing VISs
  11. Current VIS for PPSV now available in Cambodian, Hmong, Laotian, Russian, Somali, and Vietnamese
  12. Minnesota Viral Hepatitis Symposium scheduled for July 23-24 in Bloomington
 
Abbreviations
AAFP, American Academy of Family Physicians; AAP, American Academy of Pediatrics; ACIP, Advisory Committee on Immunization Practices; AMA, American Medical Association; CDC, Centers for Disease Control and Prevention; FDA, Food and Drug Administration; IAC, Immunization Action Coalition; MMWR, Morbidity and Mortality Weekly Report; NCIRD, National Center for Immunization and Respiratory Diseases; NIVS, National Influenza Vaccine Summit; VIS, Vaccine Information Statement; VPD, vaccine-preventable disease; WHO, World Health Organization.
  
Issue 807: June 22, 2009
1.  Reminder: Please take IAC's survey about immunization education materials

A big thank-you to IAC Express readers who have already responded to our survey, which we emailed on June 18. We appreciate your taking time to help IAC assess thescope of available immunization education materials and identify the topics on which materials are lacking.

If you have not yet had a chance to fill out the survey, we encourage you to do so. Here's a link to the survey form:
http://www.immunize.org/surveypm

Back to top
   
2 MMWR article reports on healthcare personnel who may have acquired novel H1N1 influenza infection from ill patients.

CDC published "Novel Influenza A (H1N1) Virus Infections Among Healthcare Personnel--United States, April-May, 2009" in the June 19 issue of MMWR. Portions of the article are reprinted below.


Soon after identification of novel influenza A (H1N1) virus infections in the United States in mid-April 2009, CDC provided interim recommendations to reduce the risk for transmission in healthcare settings. These included recommendations on use of personal protective equipment (PPE), management of healthcare personnel (HCP) after unprotected exposures, and instruction of ill HCP not to report to work. To better understand the risk for acquiring infection with the virus among HCP and the impact of infection-control recommendations, CDC solicited reports of infected HCP from state health departments. As of May 13, CDC had received 48 reports of confirmed or probable infections with novel influenza A (H1N1) virus; of these, 26 reports included detailed case reports with information regarding risk factors that might have led to infection. Of the 26 cases, 13 (50%) HCP were deemed to have acquired infection in a healthcare setting, including one instance of probable HCP to HCP transmission and 12 instances of probable or possible patient to HCP transmission. Eleven HCP had probable or possible acquisition in the community, and two had no reported exposures in either healthcare or community settings. Among 11 HCP with probable or possible patient to HCP acquisition and available information on PPE use, only three reported always using either a surgical mask or an N95 respirator. These findings suggest that transmission of novel influenza A (H1N1) virus to HCP is occurring in both healthcare and community settings and that additional messages aimed at reinforcing current infection-control recommendations are needed. . . .

Editorial Note:
Routine infection-control recommendations to decrease the risk for transmission of seasonal influenza to HCP include vaccination, isolation of infected patients in single rooms, and use of standard precautions and droplet precautions. For infections with the novel influenza A (H1N1) virus, because of the lack of a vaccine and little initial information regarding the severity and transmissibility of the virus, CDC's interim infection-control recommendations for the care of patients with such infections have included the use of fit-tested N95 respirators, eye protection, and contact precautions in addition to routine infection-control practices applied to seasonal influenza. In addition, CDC has recommended that aerosol-generating procedures (e.g., bronchoscopy) should be performed in an airborne infection-isolation room with negative pressure air handling. In this analysis, among the 11 HCP infected because of probable or possible patient to HCP transmission for whom information was available, none adhered to these recommended practices completely.

Although no data are available on why recommended practices often were not followed in these situations, similar nonadherence with recommended PPE by HCP caring for patients with febrile respiratory infections has been documented previously for influenza and other respiratory infections. Barriers to adherence can include (1) a belief that these practices are not necessary, inconvenient, or disruptive; (2) lack of availability of PPE; (3) inadequate training in infection control; (4) failure to establish effective, systematic approaches to HCP safety; and (5) failure to recognize patients and activities that warrant specific infection-control practices. In addition, some of the suboptimal practices described in this report might have occurred before CDC's interim recommendations were first issued on April 25. . . .

These results highlight the need to maintain adherence to comprehensive infection-control strategies to prevent transmission of novel H1N1 in healthcare settings. These strategies should include administrative controls (e.g., visitor policies and triage of potentially infectious patients), provision of infection-control resources, training in infection-control practices and correct use of PPE, identification of all ill HCP, and exclusion of ill HCP from work.


To access a web-text (HTML) version of the complete article, go to:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5823a2.htm

To access a ready-to-print (PDF) version of this issue of MMWR, go to:
http://www.cdc.gov/mmwr/PDF/wk/mm5823.pdf

To receive a FREE electronic subscription to MMWR (which includes new ACIP recommendations), go to:
http://www.cdc.gov/mmwr/mmwrsubscribe.html

Back to top
   
3 CDC's novel H1N1 influenza web section is updated with guidance for day/residential camps, PSAs on travel and leaving home when sick, and more

CDC recently posted new or updated information to three sub-sections of its H1N1 Flu web section. Following are the titles and URLs of documents that have been posted since the June 15 issue of IAC Express.

FROM THE "H1N1 FLU CLINICAL AND PUBLIC HEALTH GUIDANCE" SUB-SECTION
Interim CDC Guidance on Day and Residential Camps in Response to Human Infections with the Novel Influenza A (H1N1) Virus
http://www.cdc.gov/h1n1flu/camp.htm

FROM THE "NOVEL H1N1 FLU (SWINE FLU) PUBLIC SERVICE ANNOUNCEMENTS (PSAs)" SUB-SECTION
"H1N1 Travel Plans" is a 30-second audio that encourages travelers who are sick with novel H1N1 influenza to stay home, even if it means postponing their trip. It is available in English for downloading to MP3 players; a script is available.
http://www.cdc.gov/h1n1flu/psa/travelplans.htm

"H1N1 Leaving Home or Hotel Room" is a 30-second audio that encourages people who are sick with novel H1N1 influenza, but who have to leave their hotel or home to seek medical care, to wear a face mask and take other steps to protect others. It is available in English for downloading to MP3 players; a script is available.
http://www.cdc.gov/h1n1flu/psa/leavinghomehotel.htm

FROM THE "H1N1 FLU (SWINE FLU): GENERAL INFORMATION" SUB-SECTION
Questions & Answers: Novel H1N1 Flu (Swine Flu) and You
http://www.cdc.gov/h1n1flu/qa.htm


The home page of CDC's H1N1 Flu web section can be accessed from http://www.cdc.gov/h1n1flu

IAC has gathered important information related to H1N1 influenza in a new web section to make it easier to keep up to date with developments. To access this resource, go to:
http://www.immunize.org/h1n1

Back to top
   
4 WHO reports that sanofi pasteur will donate 100 million doses of pandemic H1N1 influenza vaccine

On June 17, the website of the World Health Organization (WHO) posted a statement from WHO Director-General Dr. Margaret Chan announcing that sanofi pasteur will donate 100 million doses of novel H1N1 influenza vaccine to WHO. Portions of the statement are reprinted below.


"We welcome this very generous gesture by sanofi pasteur. One hundred million doses of vaccine against the pandemic H1N1 2009 virus is a sizeable and generous gesture to and on behalf of the world's less-developed countries. WHO will now work to ensure that this vaccine gets to groups who otherwise would have no access to pandemic vaccines.

"It is gratifying that vaccine manufacturers are demonstrating their solidarity with WHO in protecting the health of the world's poorer people: influenza knows no boundaries and so to protect people in one country is to protect us all. . . ."

To access the entire statement, go to:
http://www.who.int/mediacentre/news/statements/2009/vaccine_donation_20090617

Back to top
   
5 IAC updates its website with redesigned hepatitis B and HPV web sections; links to package inserts and a sortable language-locator table are also available

IAC recently reformatted two of its web section, one on human papillomavirus (HPV) disease and vaccine and the other on hepatitis B virus disease and vaccines. IAC also has posted two useful web pages: (1) a sortable reference table of languages into which VISs and select IAC materials have been translated and (2) links to package inserts posted on vaccine manufacturers' websites. Information follows.

REDESIGNED WEB SECTIONS ON HEPATITIS B AND HPV
Each web section now offers website users easy access to resources from IAC, other organizations, and government agencies.

To access the redesigned hepatitis B web section, go to:
http://www.immunize.org/hepb

To access the redesigned HPV web section, go to:
http://www.immunize.org/hpv

LINKS TO PACKAGE INSERTS
Organized alphabetically by vaccine, the web page of package inserts saves web users time: there's no need to search for a package insert on FDA's website or on the website of a vaccine manufacturer.

To access the web page of package inserts, go to:
http://www.immunize.org/packageinserts

SORTABLE LANGUAGE-LOCATOR TABLE
Use the table to find out if IAC provides a non-English VIS or print material that could help you serve patients from a given country. The table associates and lists only those countries with non-English language translations currently offered by IAC. IAC produces non-English VISs in 36 languages and select print materials in 12 languages.

To access the language-locator table, go to:
http://www.immunize.org/vis/vis_language_table.asp

Back to top
   
6 IAC adds new Q&As to 14 of its "Ask the Experts" web sections

IAC recently updated 14 of its "Ask the Experts" web sections with new Q&As. The titles of the 14 sections appear below, along with the corresponding URLs.

For the "Ask the Experts: General" web section, go to:
http://www.immunize.org/askexperts/experts_general.asp

For the "Ask the Experts: Combination vaccines" web section, go to:
http://www.immunize.org/askexperts/experts_combo.asp

For the "Ask the Experts: Diphtheria" web section, go to:
http://www.immunize.org/askexperts/experts_diph.asp

For the "Ask the Experts: Hepatitis A" web section, go to:
http://www.immunize.org/askexperts/experts_hepa.asp

For the "Ask the Experts: Hepatitis B" web section, go to:
http://www.immunize.org/askexperts/experts_hepb.asp

For the "Ask the Experts: Human papillomavirus" web section, go to:
http://www.immunize.org/askexperts/experts_hpv.asp

For the "Ask the Experts: Measles, mumps, rubella (MMR)" web section, go to:
http://www.immunize.org/askexperts/experts_mmr.asp

For the "Ask the Experts: Meningococcal disease" web section, go to:
http://www.immunize.org/askexperts/experts_men.asp

For the "Ask the Experts: Pertussis" web section, go to:
http://www.immunize.org/askexperts/experts_per.asp

For the "Ask the Experts: Pneumococcal conjugate (PCV)" web section, go to:
http://www.immunize.org/askexperts/experts_pcv.asp

For the "Ask the Experts: Pneumococcal polysaccharide (PPSV)" web section, go to:
http://www.immunize.org/askexperts/experts_ppv.asp

For the "Ask the Experts: Tetanus" web section, go to:
http://www.immunize.org/askexperts/experts_tet.asp

For the "Ask the Experts: Varicella (chickenpox)" web section, go to:
http://www.immunize.org/askexperts/experts_var.asp

For the "Ask the Experts: Zoster (shingles)" web section, go to:
http://www.immunize.org/askexperts/experts_zos.asp

To access the index page for the entire "Ask the Experts" web section, go to:
http://www.immunize.org/askexperts

Back to top
   
7 IAC's Video of the Week features a polio survivor's story about her 60 years in an iron lung

IAC encourages IAC Express readers to watch a 2-minute video about polio survivor Martha Mason, who lived in an iron lung from age 11 until her death in May 2009 at age 71. A 4-minute audio retrospective of Ms. Mason's life was broadcast on National Public Radio (NPR) shortly after her death; a link to it is given at the end of this IAC Express article.

The video will be available on the home page of IAC's website through June 28. To access it, go to: http://www.immunize.org and click on the image under the words Video of the Week, which you'll find toward the top of the page. It may take a few moments for the video to begin playing; please be patient!

Remember to bookmark IAC's home page to view a new video every Monday. While you're at our home page, we encourage you to browse around--you're sure to find resources and information that will enhance your practice's immunization delivery.

All the videos featured as an IAC Video of the Week have recently been archived in a new section of IAC's website. To view any of the videos previously featured, go to:
http://www.immunize.org/votw/may09.asp

To access the NPR audio retrospective, go to:
http://www.npr.org/templates/story/story.php?storyId=104032600

Back to top
   
8 FDA enforces laws to protect consumers from Internet marketing of illegal products related to novel H1N1 influenza

On June 15, FDA issued a news release titled "FDA Warns Web Sites against Marketing Fraudulent H1N1 Flu Virus Claims." A portion of the news release is reprinted below.


On May 1, 2009, the FDA warned consumers regarding products related to the 2009 H1N1 flu virus offered on the Internet. The products involved are those that are promoted and marketed to diagnose, mitigate, prevent, treat, or cure the 2009 H1N1 flu virus but are not approved, cleared, or authorized by the FDA. The agency advised operators of offending Web sites that they must take immediate action to ensure that they are not marketing products intended to diagnose, mitigate, prevent, treat, or cure the 2009 H1N1 flu virus that have not been cleared, approved, or authorized by the FDA.

Since then, the FDA has issued more than 50 warning letters to offending Web sites and as a result, more than 66 percent of these Web sites have removed the offending claims and/or products. . . .

The FDA will consider further civil or criminal enforcement action against those Web sites that fail to resolve the violations cited in warning letters. Actions could include seizure, injunction, and criminal prosecution.

For more information:

FDA's Fraudulent H1N1 Influenza Virus Products List:
http://www.accessdata.fda.gov/scripts/h1n1flu

Browse Warning Letters for: Unapproved/Uncleared/Unauthorized Products Related to the H1N1 Flu Virus:
http://www.accessdata.fda.gov/scripts/warningletters/wlFilterBySubject.cfm

Report Suspected Fraudulent Products or Criminal Activity Associated with H1N1 Flu Virus (Swine Flu):
http://www.fda.gov/ICECI/CriminalInvestigations/ucm162855.htm

To access the entire news release, go to:
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm166801.htm

Back to top
   
9 Order laminated U.S. immunization schedules today!

IAC has two laminated immunization schedules for 2009--one for children/teens ages 0 through 18 years and one for adults. Based on CDC's 2009 immunization schedules, the laminated schedules offer two significant advantages over paper schedules:

(1) They are covered with a tough, washable coating that lets them stand up to a year's worth of use as at-your-fingertips guides to immunization and as teaching tools you can use to give patients and parents authoritative immunization information.

(2) Each schedule includes a guide to vaccine contraindications and precautions, an additional feature that will help you to make on-the-spot determinations about vaccinating patients of any age.

IAC's laminated schedules come complete with essential footnotes and are printed in color for easy reading. Each schedule has six pages (i.e., three double-sided pages), and when folded, measures 8.5" x 11".

For specific information about the child/teen schedule, to view images of it, or to order online or download an order
form, visit http://www.immunize.org/shop/schedule_child.asp

For specific information about the adult schedule, to view images of it, or to order online or download an order form,
visit http://www.immunize.org/shop/schedule_adult.asp

Prices start at $10 each for 1-4 copies and drop to $6.50 each for 5-19 copies. Discount pricing is available for 20 or more copies. For quotes on customizing or placing orders in excess of 999 schedules, call (651) 647-9009 or email admininfo@immunize.org

To learn about other essential immunization resources available for purchase from IAC, such as personal immunization record cards, padded screening questionnaires, and educational videos, go to: http://www.immunize.org/shop

Back to top
   
10.  CDC updates its online VIS fact sheet with information about new options for distributing VISs

On June 16, CDC updated its comprehensive online "Fact Sheet for Vaccine Information Statements." The Provider Responsibilities Section of the fact sheet now has information regarding new options for distributing VISs. The new options include (1) using permanent (e.g., laminated) copies for patients to read in the medical office and (2) allowing patients the option of downloading VISs to their personal mobile devices instead of giving them paper copies to take with them.

To access the updated fact sheet, go to:
http://www.cdc.gov/vaccines/pubs/vis/vis-facts.htm

Back to top
   
11.  Current VIS for PPSV now available in Cambodian, Hmong, Laotian, Russian, Somali, and Vietnamese

Dated 4/16/09, the VIS for pneumococcal polysaccharide vaccine (PPSV) is now available in Cambodian, Hmong, Laotian, Russian, Somali, and Vietnamese. IAC gratefully acknowledges the Minnesota Department of Health for the translations.

To access the Cambodian version of the VIS for PPSV, go to:
http://www.immunize.org/vis/ca_pne97.pdf

To access the Hmong version of the VIS for PPSV, go to:
http://www.immunize.org/vis/hm_pne97.pdf

To access the Laotian version of the VIS for PPSV, go to:
http://www.immunize.org/vis/la_pne97.pdf

To access the Russian version of the VIS for PPSV, go to:
http://www.immunize.org/vis/ru_pne97.pdf

To access the Somali version of the VIS for PPSV, go to:
http://www.immunize.org/vis/so_pne97.pdf

To access the Vietnamese version of the VIS for PPSV, go to:
http://www.immunize.org/vis/vn_pne97.pdf

To access the English version of the VIS for PPSV, go to:
http://www.immunize.org/vis/pneum3.pdf

NOTE: The 6/16/09 VIS for PPSV vaccine comes in additional languages, including Spanish. To access them, go to: http://www.immunize.org/vis/vis_ppsv.asp Click on the link to the pertinent language.

For information about the use of VISs, and for VISs in more than 35 languages, visit IAC's VIS web section at http://www.immunize.org/vis

For general information about VISs from CDC's website go to:
http://www.cdc.gov/vaccines/pubs/vis

Back to top
   
12.  Minnesota Viral Hepatitis Symposium scheduled for July 23-24 in Bloomington

The Minnesota Viral Hepatitis Symposium will be held in Bloomington on July 23-24. It is presented by the Upper Midwest chapter of the American Liver Foundation and the Minnesota Department of Health.

The deadline for early registration is July 1.

For comprehensive information, including registration information, go to:
http://www.liverfoundation.org/chapters/upper_midwest/events/474

Back to top
   
Immunization Action Coalition  •  2550 University Avenue West  •  Suite 415 North  •  Saint Paul, Minnesota  •  55114
tel 651-647-9009  •  fax 651-647-9131
 
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC.